117 Results for "

Pyruvate Kinase

" in MedChemExpress (MCE) Product Catalog:
Products (117)

117 Results for "Pyruvate Kinase" in MCE Product Catalog:

Cat. No.: HY-P2806
CAS No.: 9001-59-6
Synonyms: PK; FluoroKinase
Pyruvate Kinase, Microorganism (PK) is a glycolytic enzyme that catalyzes the conversion of phosphoenolpyruvate and ADP to pyruvate and ATP .
loading...
    loading...
Cat. No.: HY-136882
CAS No.: 921099-13-0
Purity:  95.04%
Target:  

PDHK

Research Areas:  

Cancer

TM-1 is a potent inhibitor of pyruvate dehydrogenase kinase (PDHK1). TM-1 inhibits PDHK1 and PDHK2 with IC50s of 2.97 μM and 5.2 μM, respectively. TM-1 blocks pyruvate dehydrogenase complex (PDHC) phosphorylation, and inhibits cell proliferation .
loading...
    loading...
Cat. No.: HY-P2806A
CAS No.: 9001-59-6
Synonyms: ATP:Pyruvate 2-0-phosphotransferase,PK
Target:  

Pyruvate Kinase

Research Areas:  

Metabolic Disease Cancer

Pyruvate Kinase (PK),Rabbit Muscle (ATP:Pyruvate 2-0-phosphotransferase,PK) is a biological material or organic compound that can be used in life science research .
loading...
    loading...
Cat. No.: HY-138825
CAS No.: 1039980-33-0
Purity:  ≥95.0%
Target:  

Pyk2

Research Areas:  

Metabolic Disease

NCGC00188636 is a novel covalent pyruvate kinase (PYK) inhibitor. NCGC00188636 blocks nucleotide binding to the active site of pyruvate kinase. NCGC00188636 can be used for the research of the metabolism of many organisms and cell types.
loading...
    loading...
Cat. No.: HY-135884
CAS No.: 2283422-04-6
Purity:  99.12%
Synonyms: AG-946; PKR activator 2
Target:  

Pyruvate Kinase

Research Areas:  

Cardiovascular Disease

Tebapivat (PKR activator 2) is a potent pyruvate kinase-R (PKR) activator extracted from patent WO2019035863A1, compound 385 .
loading...
    loading...
Cat. No.: HY-139573
CAS No.: 2245053-57-8
Purity:  99.91%
Synonyms: FT-4202
Target:  

Pyruvate Kinase

Research Areas:  

Cardiovascular Disease

Etavopivat is a potent, selective, and orally active erythrocyte pyruvate kinase (PKR) activator. Etavopivat has potent antisickling effects that can be used in studies of sickle cell disease and other haemoglobinopathies .
loading...
    loading...
Cat. No.: HY-W005629
CAS No.: 1446-61-3
Research Areas:  

Metabolic Disease Cancer

Leelamine is an orally active pyruvate dehydrogenase kinase (PDK) inhibitor with an IC50 value of 9.5 μM, showing a blood glucose lowering effect in the diabetic mouse. Leelamine is also a weak agonist of cannabinoid receptors CB1 and CB2. Leelamine decreases mitotic activity, prostate-specific antigen expression and induces Apoptosis to cell death in cancer cells .
loading...
    loading...
Cat. No.: HY-N6663
CAS No.: 13466-78-9
3-Carene is an orally active TCA cycle enzyme inhibitor. 3-Carene inhibits succinate dehydrogenase and malate dehydrogenase as well as pyruvate kinase, disrupting energy metabolism. 3-Carene disrupts cell wall and cell membrane integrity, leading to potassium ion leakage, protein leakage, membrane depolarization, ATP depletion, morphological disruption, and cell lysis. 3-Carene interferes with amino acid metabolism, pantothenate and CoA biosynthesis, purine and pyrimidine metabolism, and aminoacyl-tRNA biosynthesis. 3-Carene enhances GABA receptor-mediated synaptic responses. 3-Carene can be used in research on bacterial infections, inflammation, anxiety, and sleep disorders .
loading...
    loading...
Cat. No.: HY-147368
CAS No.: 1186660-06-9
Purity:  99.48%
Target:  

Pyruvate Kinase

Research Areas:  

Cancer

PKM2 activator 2 (compound 28) is a pyruvate kinase M2 (PKM2) activitor with an AC50 value of 66 nM. PKM2 activator 2 can restore normal glycolytic metabolism in cells .
loading...
    loading...
Cat. No.: HY-19702
CAS No.: 1628428-01-2
Target:  

Pyruvate Kinase

Research Areas:  

Metabolic Disease

PKR activator 3 (Compound 160) is a red blood cell pyruvate kinase (PKR) activator. PKR activator 3 can be used in the research of diseases related to PKR function, such as pyruvate kinase deficiency (PKD) .
loading...
    loading...
Cat. No.: HY-148615
CAS No.: 1040706-91-9
Purity:  99.69%
Target:  

Pyruvate Kinase

Research Areas:  

Cancer

NPD10084 is a pyruvate kinase PKM2 inhibitor that inhibits non-glycolytic signaling in cancer cells. NPD10084 disrupts the interaction between PKM2 and β-catenin or STAT3 and inhibits downstream signaling. NPD10084 has antiproliferative activity against colorectal cancer cells in vitro and in vivo .
loading...
    loading...
Cat. No.: HY-149814
CAS No.: 2897696-10-3
Purity:  99.74%
Target:  

PDHK HSP

Research Areas:  

Cancer

PDK-IN-1 (compound 7o) is a pyruvate dehydrogenase kinase (PDK) inhibitor. PDK-IN-1 shows IC50 values of 0.03 and 0.1 μM for PDK1 and HSP90, respectively. PDK-IN-1 targets PDH/PDK axis thus reducing efficiently the tumor mass .
loading...
    loading...
Cat. No.: HY-161337
CAS No.: 3078059-66-9
Target:  

Pyruvate Kinase

Research Areas:  

Metabolic Disease

PKL-IN-1 is a potent inhibitor of pyruvate kinase (PKL) with an IC50 of 0.07 μM. PKL-IN-1 can be used in the study of non-alcoholic fatty liver disease .
loading...
    loading...
Cat. No.: HY-N15451
CAS No.: 112515-42-1
Deoxytopsentin (compound 5) is a marine bisindole alkaloid and also a MRSA pyruvate kinase inhibitor. Deoxytopsentin exists in sponges. Deoxytopsentin exhibits antibacterial activity against methicillin-resistant Staphylococcus aureus strains in vitro .
loading...
    loading...
Cat. No.: HY-157299
CAS No.: 3057973-22-2
Purity:  99.87%
Target:  

PDHK

Research Areas:  

Cancer

PDK-IN-3 (compound 1) is a potent pan inhibitor of PDK with IC50s of 109.3, 135.8, 458.7 nM and 8.67 μM against PDK 1-4, respectively. PDK-IN-3 also induces proliferation and apoptosis in A549 cells .
loading...
    loading...
Cat. No.: HY-146552
CAS No.: 3065641-69-9
Target:  

PDHK

Research Areas:  

Metabolic Disease Cancer

PDHK-IN-4 (Compound 30) is a potent inhibitor of PDHK with IC50s of 0.0051 and 0.0122 μM for PDHK2 and PDHK4, repectively. Pyruvate dehydrogenase kinases (PDHKs) are fascinating agent targets for numerous diseases, including diabetes and cancers. PDHK-IN-4 has the potential for the research of cancer diseases .
loading...
    loading...
Cat. No.: HY-P10338
CAS No.: 1423743-97-8
LZ1 peptide acts as a Pyruvate kinase inhibitor, antimicrobial agent, and antimalarial agent. LZ1 peptide reduces ATP production and inhibits the malaria parasite Plasmodium falciparum. LZ1 peptide exhibits activity against Plasmodium berghei in mice and reduces parasitemia. LZ1 peptide shows favorable antimicrobial activity against pathogens associated with acne vulgaris. LZ1 peptide possesses anti-inflammatory effects. LZ1 peptide can be used in malaria-related research .
loading...
    loading...
Cat. No.: HY-119874
CAS No.: 23444-65-7
Alkannin is a potent and specific inhibitor of tumor-specific pyruvate kinase-M2 (PKM2). Alkannin does not inhibit PKM1 and pyruvate kinase-L (PKL). Alkannin acts as a potential anticancer agent .
loading...
    loading...
Cat. No.: HY-111936
CAS No.: 562867-96-3
Synonyms: BML283
Target:  

Pyruvate Kinase

Research Areas:  

Cancer

ML083 is a member of a series of highly specific allosteric activators for the tumor-specific isoform of human pyruvate kinase (M2 isoform). ML083 affects the cooperativity of phosphoenolpyruvate (PEP) binding. ML083 can be used in the research of tumors .
loading...
    loading...
Cat. No.: HY-155850
CAS No.: 2649154-82-3
Purity:  99.70%
Target:  

Pyruvate Kinase

Research Areas:  

Neurological Disease

CIAC001 is a Pyruvate Kinase PKM2 inhibitor with anti-neuroinflammatory activity. CIAC001 inhibits LPS-induced proinflammatory nitric oxide (NO) production and protects immunologically active BV-2 cells (IC50=2.5 μM). CIAC001 also has anti-neuroinflammation in mouse models and inhibits chronic morphine-induced addiction .
loading...
    loading...